4//SEC Filing
Patel Jeegar Pravinkumar 4
Accession 0002092017-25-000007
CIK 0002044725other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:21 PM ET
Size
6.9 KB
Accession
0002092017-25-000007
Insider Transaction Report
Form 4
Evommune, Inc.EVMN
Patel Jeegar Pravinkumar
Chief Scientific Officer
Transactions
- Conversion
Series B Preferred Stock
2025-11-07−25,000→ 0 total→ Common Stock (3,175 underlying) - Conversion
Common Stock
2025-11-07+3,175→ 57,091 total
Footnotes (1)
- [F1]Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date.
Documents
Issuer
Evommune, Inc.
CIK 0002044725
Entity typeother
Related Parties
1- filerCIK 0002092017
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:21 PM ET
- Size
- 6.9 KB